Catalase, a remarkable enzyme: targeting the oldest antioxidant enzyme to find a new cancer treatment approach
2017 · Biological Chemistry · 625 citations
https://doi.org/10.1515/hsz-2017-0131
C
Christophe Glorieux
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
2.9K
Citations
27
h-index
38
i10-index
Christophe Glorieux is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Genomics, phytochemicals, and oxidative stress & Cancer, Hypoxia, and Metabolism & Vitamin C and Antioxidants Research. The author has an h-index of 27, co-authored 41 publications.
ORCID: 0000-0003-1944-611XPapers by this author
worksTargeting ROS in cancer: rationale and strategies
2024 · Nature Reviews Drug Discovery · 471 citations
https://doi.org/10.1038/s41573-024-00979-4
Targeting catalase in cancer
2024 · Redox Biology · 53 citations
https://doi.org/10.1016/j.redox.2024.103404
Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling
2021 · Molecular Metabolism · 44 citations
https://doi.org/10.1016/j.molmet.2021.101203
CD137 expression in cancer cells: regulation and significance
2019 · Cancer Communications · 17 citations
https://doi.org/10.1186/s40880-019-0419-z
The complex interplay between redox dysregulation and mTOR signaling pathway in cancer: A rationale for cancer treatment
2024 · Biochemical Pharmacology · 6 citations
https://doi.org/10.1016/j.bcp.2024.116729
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat